BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11001697)

  • 1. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis.
    Pérez de Nanclares G; Castaño L; Gaztambide S; Bilbao JR; Pi J; González ML; Vázquez JA
    N Engl J Med; 2000 Sep; 343(12):891. PubMed ID: 11001697
    [No Abstract]   [Full Text] [Related]  

  • 2. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemochromatosis and diabetes mellitus.
    Hegele RA; Harris SB; Zinman B
    Ann Intern Med; 1998 Oct; 129(7):587. PubMed ID: 9758583
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary haemochromatosis mutations (HFE) in patients with Type II diabetes mellitus.
    Braun J; Donner H; Plock K; Rau H; Usadel KH; Badenhoop K
    Diabetologia; 1998 Aug; 41(8):983-4. PubMed ID: 9726605
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study.
    Salonen JT; Tuomainen TP; Kontula K
    BMJ; 2000 Jun; 320(7251):1706-7. PubMed ID: 10864547
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
    Dubois-Laforgue D; Caillat-Zucman S; Djilali-Saiah I; Larger E; Mercadier A; Boitard C; Bach JF; Timsit J
    Diabetes Care; 1998 Aug; 21(8):1371-2. PubMed ID: 9702455
    [No Abstract]   [Full Text] [Related]  

  • 8. HFE genotype in patients with hemochromatosis and other liver diseases.
    McLaren GD
    Ann Intern Med; 2000 Feb; 132(3):245; author reply 246. PubMed ID: 10651611
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients.
    Altes A; Ruiz A; Martinez C; Esteve A; Vela MD; Remacha AF; Sarda P; Bach V; Baiget M
    Ann Hematol; 2007 Nov; 86(11):831-5. PubMed ID: 17639389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE genotype in patients with hemochromatosis and other liver diseases.
    Powell LW
    Ann Intern Med; 2000 Feb; 132(3):245-6. PubMed ID: 10651612
    [No Abstract]   [Full Text] [Related]  

  • 11. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis.
    Rees DC; Singh BM; Luo LY; Wickramasinghe S; Thein SL
    Ann N Y Acad Sci; 1998 Jun; 850():490-4. PubMed ID: 9668593
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron overload: molecular clues to its cause.
    Kühn LC
    Trends Biochem Sci; 1999 May; 24(5):164-6. PubMed ID: 10322426
    [No Abstract]   [Full Text] [Related]  

  • 13. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE Genotypes and iron overload in patients with suspected coronary heart disease but normal angiograms.
    Stöllberger C; Mölzer G; Krugluger W; Finsterer J
    Int J Cardiol; 2002 Jan; 82(1):63-4. PubMed ID: 11786160
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
    Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
    Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis and cancer risk: more fuel to the fire?
    Mallory MA; Kowdley KV
    Gastroenterology; 2001 Nov; 121(5):1253-4. PubMed ID: 11677223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.